NCX4016
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NCX4016, covering 2011-01-19 to 2015-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy [Phase 2]